GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 221 filers reported holding GUARDANT HEALTH INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $368,000 | -33.6% | 9,129 | +9.1% | 0.00% | 0.0% |
Q1 2022 | $554,000 | -54.1% | 8,364 | -30.7% | 0.00% | -50.0% |
Q4 2021 | $1,207,000 | -20.1% | 12,070 | -0.1% | 0.00% | -20.0% |
Q3 2021 | $1,511,000 | -30.9% | 12,087 | -31.4% | 0.01% | -37.5% |
Q2 2021 | $2,188,000 | -19.5% | 17,616 | -1.1% | 0.01% | -20.0% |
Q1 2021 | $2,719,000 | +41.2% | 17,809 | +19.2% | 0.01% | +42.9% |
Q4 2020 | $1,925,000 | -33.0% | 14,940 | -41.9% | 0.01% | -41.7% |
Q3 2020 | $2,874,000 | +83.4% | 25,713 | +33.1% | 0.01% | +71.4% |
Q2 2020 | $1,567,000 | +15.3% | 19,315 | -1.1% | 0.01% | -12.5% |
Q1 2020 | $1,359,000 | -2.6% | 19,526 | +9.4% | 0.01% | +14.3% |
Q4 2019 | $1,395,000 | +6.1% | 17,856 | -13.3% | 0.01% | -12.5% |
Q3 2019 | $1,315,000 | -22.4% | 20,600 | +5.0% | 0.01% | -20.0% |
Q2 2019 | $1,694,000 | +2.9% | 19,628 | -8.6% | 0.01% | 0.0% |
Q1 2019 | $1,647,000 | +126.5% | 21,478 | +11.0% | 0.01% | +100.0% |
Q4 2018 | $727,000 | – | 19,350 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |